Rate My Professor Gabe Kwong

Dr. Gabe A. Kwong is the Robert A. Milton Endowed Chair Professor of Biomedical Engineering in the Wallace H. Coulter Department of Biomedical Engineering at the Georgia Institute of Technology and Emory School of Medicine. He earned a B.S. in Bioengineering with Highest Honors from the University of California, Berkeley, a Ph.D. in Bioengineering from the California Institute of Technology, and completed postdoctoral studies at the Massachusetts Institute of Technology with Professor Sangeeta N. Bhatia. Kwong joined the Georgia Tech faculty in 2014 and directs the Laboratory for Synthetic Immunity. His research program operates at the interface of synthetic immunity, engineering, and medicine, developing in vivo biosensors for early detection and monitoring of disease, particularly cancer, and engineering technologies to track, control, and program immune cell therapies. Key areas include cancer technologies, immunoengineering, and biomaterials and regenerative technologies. He leads the $49.5 million Cancer and Organ Degradome Atlas (CODA) project, a multi-institutional effort funded by ARPA-H to revolutionize multi-cancer early detection.

Kwong has co-founded multiple biotechnology companies and holds over 40 issued or pending patents. His publications feature in leading journals such as Nature Cancer, Nature Nanotechnology, Science Advances, Nature Biomedical Engineering, and Nature Reviews Cancer. Notable works include “Sensitizing solid tumors to CAR-mediated cytotoxicity by lipid nanoparticle delivery of synthetic antigens” (Nature Cancer, 2025), “AND-gated protease-activated nanosensors for programmable detection of anti-tumour immunity” (Nature Nanotechnology, 2025), “In vivo mRNA delivery to virus-specific T cells by light-induced ligand exchange of MHC class I antigen-presenting nanoparticles” (Science Advances, 2022), and “Synthetic Biomarkers: A 21st century path to early cancer detection” (Nature Reviews Cancer, 2021). He has received the NIH Director’s New Innovator Award (2016), NIH Director’s Pioneer Award (2022), Burroughs Wellcome Fund Career Award at the Scientific Interface (2013), Fellow of the American Institute for Medical and Biological Engineering (2024), Sigma Xi Best Faculty Paper Award (2020), and Georgia Tech CTL/British Petroleum Junior Faculty Teaching Excellence Award (2018), among others. His innovations have advanced immunoengineering and cancer diagnostics.